Jim Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT, as well as a Member of the Harvard-MIT Health Sciences & Technology Faculty. He is also the Co-founder of Radar therapeutics, along with Synlogic, Senti Biosciences, Sherlock Biosciences, Cellarity, and Phare Bio

The Collins research group works in synthetic biology and systems biology, with a particular focus on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance. He has received numerous awards and honors, including a MacArthur "Genius" Award and the Dickson Prize in Medicine, and he is an elected member of all three national academies - the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine.